Sugi Predict

Sugi Predict / Compounds / SCHEMBL2879894

SCHEMBL2879894

SCHEMBL2879894

Cc1ccc(-c2ccc(-c3nc(-c4ccc(-c5ccc(C)cc5)cc4)nc(-c4ccc(-c5ccc(C)cc5)cc4)n3)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.50
▸ ACHE P22303 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ CYP1A2 P05177 2/20 0.47
▸ CYP1A1 P04798 1/20 0.47
▸ CYP1B1 Q16678 1/20 0.47
▸ NPC1 O15118 5/20 0.47
▸ RAB9A P51151 5/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ ENPP3 O14638 1/20 0.46
▸ ENPP1 P22413 1/20 0.46
▸ ADORA3 P0DMS8 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ ADORA1 P30542 1/20 0.46
▸ LMNA P02545 1/20 0.46
▸ PTBP1 P26599 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2876376 1.00 L3MBTL1 (0.50) L3MBTL1ACHETDP1CYP1A2CYP1A1
SCHEMBL15025989 1.00 L3MBTL1 (0.50) L3MBTL1ACHETDP1CYP1A2CYP1A1
SCHEMBL11810896 0.97 L3MBTL1 (0.52) L3MBTL1ACHETDP1CYP1A2CYP1A1
SCHEMBL6111135 0.97 L3MBTL1 (0.52) L3MBTL1ACHETDP1CYP1A2CYP1A1
SCHEMBL13231717 0.94 L3MBTL1 (0.50) L3MBTL1ACHETDP1CYP1A2CYP1A1
SCHEMBL12622363 0.90 L3MBTL1 (0.67) L3MBTL1TDP1CYP1A2CYP1A1CYP1B1
SCHEMBL15025684 0.90 ADORA3 (0.43) L3MBTL1CYP1A2CYP1A1CYP1B1NPC1
SCHEMBL13819656 0.90 L3MBTL1 (0.67) L3MBTL1TDP1CYP1A2CYP1A1CYP1B1
SCHEMBL12628245 0.90 L3MBTL1 (0.67) L3MBTL1TDP1CYP1A2CYP1A1CYP1B1
SCHEMBL10330368 0.90 L3MBTL1 (0.67) L3MBTL1TDP1CYP1A2CYP1A1CYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 — — US claimed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 — — US claimed
EP-3492144-A1 STABILIZATION OF COSMETIC COMPOSITIONS AGAINST PHOTODEGRADATION BASF SE (DE) 2019-06-05 — — EP disclosed
EP-2180878-B1 STABILIZATION OF COSMETIC COMPOSITIONS BASF SE (DE) 2019-01-16 — — EP disclosed
US-9691991-B2 Organic light emitting diode LG CHEM, LTD. (KR) 2017-06-27 — — US disclosed
US-9691991-B2 Organic light emitting diode LG CHEM, LTD. (KR) 2017-06-27 — — US disclosed
US-20150250695-A1 STABILIZATION OF COSMETIC COMPOSITIONS BASF SE (DE) 2015-09-10 — — US disclosed
US-20150250695-A1 STABILIZATION OF COSMETIC COMPOSITIONS BASF SE (DE) 2015-09-10 — — US disclosed
US-9066872-B2 Stabilization of cosmetic compositions BASF SE (DE) 2015-06-30 — — US disclosed
US-9066872-B2 Stabilization of cosmetic compositions BASF SE (DE) 2015-06-30 — — US disclosed
US-9048442-B2 Composition containing a metal complex and organic compound, and light-emitting element using said compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-02 — — US disclosed
EP-1743011-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) 2007-01-17 — — EP disclosed
US-20060251920-A1 Organic light emitting devices comprising a doped triazine electron transport layer XEROX CORPORATION 2006-11-09 — — US disclosed
US-20060251919-A1 Organic light emitting devices XEROX CORPORATION 2006-11-09 — — US disclosed
US-20060135766-A1 Electroluminescent device CIBA SPECIALTY CHEMICALS CORP. 2006-06-22 — — US disclosed
EP-1597938-A2 ELECTROLUMINESCENT DEVICE Ciba SC Holding AG (CH) 2005-11-23 — — EP disclosed
WO-2005105950-A1 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-11-10 — — WO disclosed
US-6821643-B1 SATISFACTORY EMISSION IN THE VISIBLE SPECTRUM FROM BLUE TO LONGER WAVELENGTH REGIONS XEROX CORPORATION 2004-11-23 — — US disclosed
WO-2004077885-A2 ELECTROLUMINESCENT DEVICE CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2004-09-10 — — WO disclosed
US-6225467-B1 UNIFORM LUMINESCENCE, ELECTROLUMINESCENT EFFICIENCY, DURABILITY, LOW DRIVING VOLTAGE; FOR USE IN FLAT-PANEL EMISSIVE DISPLAY TECHNOLOGIES, INCLUDING TELEVISION SCREENS, COMPUTER SCREENS XEROX CORPORATION 2001-05-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060135766-A1 Electroluminescent device TAAR5, TYR, TRPC5 L3MBTL1 1776/4885ACHE 219/4885TDP1 3056/4885
US-20150250695-A1 STABILIZATION OF COSMETIC COMPOSITIONS C1S, C1R, C9 L3MBTL1 906/4885ACHE 3403/4885TDP1 3455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.